Myopia (nearsightedness) is increasing at an alarming rate worldwide. By 2050, half the global population is projected to be myopic. In the United States, myopia prevalence has nearly doubled over the past 40 years — and children are developing it earlier than ever.
Every additional diopter of myopia significantly increases the lifetime risk of:
Up to 5x higher risk with high myopia — a sight-threatening emergency.
A leading cause of irreversible central vision loss in myopic adults.
2–3x increased glaucoma risk and significantly earlier cataract onset.
Important: The goal of myopia control is to slow progression during childhood — reducing the final prescription and, more importantly, the lifetime risk of sight-threatening disease.
Recognise the Signs
Squinting to see the board at school, the television, or road signs.
Holding books, tablets, or phones unusually close to the face.
Complaints of headaches or eye fatigue, especially after school.
Needing a stronger glasses prescription at every annual exam.
One or both parents are nearsighted — a major genetic risk factor.
Research links less time outdoors to higher myopia development risk.
Dr. Patel lectures across Texas on myopia control and prism therapy, staying at the forefront of treatment advances.
We have managed myopia for over 250 children with documented, measurable results.
Ortho-K, MiSight, Stellest, and atropine — we match the right treatment to your child.
Conveniently located at 2600 Lakeside Parkway, Suite 180, Flower Mound, TX 75022 — proudly serving Flower Mound, Highland Village, Lewisville, Grapevine, Coppell, Lantana, Argyle, and the greater DFW area.
Frequently Asked Questions
Myopia control refers to evidence-based treatments designed to slow the progression of nearsightedness in children. This matters because higher myopia significantly increases the lifetime risk of serious eye diseases including retinal detachment, glaucoma, macular degeneration, and cataracts. Slowing progression during childhood reduces these long-term risks.
Myopia control is most effective when started early — ideally between ages 6 and 12, when the eyes are growing most rapidly. However, treatment can still be beneficial for teenagers whose myopia is progressing. Dr. Patel will evaluate your child's specific risk factors and progression rate to determine the best time to begin.
Ortho-K involves specially designed rigid gas-permeable contact lenses worn overnight while your child sleeps. The lenses gently reshape the cornea so your child can see clearly the next day without glasses or contacts. Clinical studies show Ortho-K slows myopia progression by 40 to 60 percent on average.
Yes. All myopia control treatments offered at PersonalEyes — including Ortho-K, MiSight daily lenses, Stellest spectacle lenses, and low-dose atropine drops — have been extensively studied in clinical trials involving thousands of children. Dr. Patel monitors every patient closely and adjusts treatment as needed.
Costs vary depending on the treatment approach. Some vision insurance plans provide partial coverage for specialty contact lenses. Our team will review your benefits and provide a transparent cost breakdown during your consultation. Many families find that the long-term savings from preventing high myopia far outweigh the upfront investment.